Overview

Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.

Eligibility

Inclusion Criteria:

• Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion
• Ability to give a written informed consent and willingness to return for follow-up

Exclusion Criteria:

• Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy < 6 months in the absence of VT
• Any condition that is deemed a contraindication in the judgment of the investigators